Andrzej Przybylski

ORCID: 0000-0002-8136-7589
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiac pacing and defibrillation studies
  • Cardiac Arrhythmias and Treatments
  • Cardiac electrophysiology and arrhythmias
  • Atrial Fibrillation Management and Outcomes
  • Cardiomyopathy and Myosin Studies
  • Neurological disorders and treatments
  • Cardiovascular Effects of Exercise
  • Heart Failure Treatment and Management
  • Cardiovascular Syncope and Autonomic Disorders
  • ECG Monitoring and Analysis
  • Cardiac Structural Anomalies and Repair
  • Cardiovascular Function and Risk Factors
  • Cardiovascular Issues in Pregnancy
  • Acute Myocardial Infarction Research
  • Cardiac Health and Mental Health
  • Trauma Management and Diagnosis
  • Cardiac Valve Diseases and Treatments
  • Neuroscience and Neural Engineering
  • Palliative Care and End-of-Life Issues
  • Wireless Body Area Networks
  • Cardiac Arrest and Resuscitation
  • Long-Term Effects of COVID-19
  • Cardiovascular and exercise physiology
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Viral Infections and Immunology Research

Rzeszów University
2015-2024

Corona (Poland)
2002-2024

Grochowski Hospital
2022

Institute of Cardiology
2007-2021

Wojewódzki Szpital Zespolony
2017-2021

Medical University of Silesia
2018-2019

Silesian Center for Heart Disease
2018

Cardinal Stefan Wyszyński University in Warsaw
2010

The Arrhythmia Institute
2010

Jan Długosz University
2008

The benefits of rehabilitation in heart failure (HF) patients are well established. Little is known about Nordic walking (NW) training HF especially those with cardiovascular implantable electronic devices (CIEDs). purpose this study was to assess safety, effectiveness, adherence and acceptance home-based telemonitored NW patients, including CIEDs (i.e. cardiac resynchronisation therapy, cardioverter-defibrillator). design a single-centre, prospective, parallel-group, randomised (2:1),...

10.1177/2047487314551537 article EN European Journal of Preventive Cardiology 2014-09-26

The goal of this study was to describe mapping and ablation severe arrhythmias during pregnancy, with minimum or no X-ray exposure. Treatment tachyarrhythmia in pregnancy is a clinical problem. Pharmacotherapy entails risk adverse effects unsuccessful some patients. Radiofrequency has been performed rarely, because fetal exposure potential maternal fetus complications. GROUP AND METHOD: Mapping 9 women (age 24-34 years) at 12-38th week pregnancy. Three had permanent junctional reciprocating...

10.1111/j.1540-8167.2010.01727.x article EN Journal of Cardiovascular Electrophysiology 2010-02-11

Having several recently published reports on increased rate of cardiac perforation with some lead models as background, we assess the relation between perforations and leads used.All pacing defibrillation implantations 1 January 2007 31 March 2008 were analysed retrospectively. There 2247 implanted in 1419 patients aged 67.6 +/- 14.1, 1200 (53%) active 1047 (47%) passive fixation leads. Cardiac occurred eight (0.5%). The number does not differ significantly pacemaker implantable cardioverter...

10.1093/europace/eun363 article EN EP Europace 2008-11-04

ICD in Hypertrophic Cardiomyopathy Patients. Introduction: Although implantable cardioverter‐defibrillators (ICDs) are used sudden cardiac death (SCD) prevention high‐risk patients with hypertrophic cardiomyopathy (HCM), long‐term results as well precise risk stratification discussed a limited number of reports. The aim the study was to assess incidence intervention HCM relation clinical profile. Methods and Results: We studied 104 consecutive implanted single center. mean age population...

10.1111/j.1540-8167.2009.01716.x article EN Journal of Cardiovascular Electrophysiology 2010-02-01

The purpose of this patient survey was to analyse the knowledge, experiences, and attitudes regarding cardiac implantable electronic devices (CIED) in patients with pacemakers, cardioverter-defibrillators (ICDs), or resynchronization devices. Of 1644 CIEDs from seven European countries, 88% were over 50 years age. Most (90%) knew what device they implanted felt sufficiently informed about indications for therapy. As many as 42% needed additional information on battery replacement limitations...

10.1093/europace/eux365 article EN EP Europace 2017-12-28

Telemedicine is intended to provide medical care patients in remote areas. This study sought investigate whether the application of e-health solutions for with heart failure (HF) who live regions social exclusion would improve their functional performance and quality life (QoL). In this prospective, non-controlled carried out between June December 2023, HF were enrolled 14 primary units located 5 rural voivodeships eastern Poland. All evaluated at baseline after 3 months using New York Heart...

10.20452/pamw.16954 article EN Polskie Archiwum Medycyny Wewnętrznej 2025-02-13

Permanent cardiac pacing is a recognized method of treatment patients with sick sinus syndrome and/or atrioventricular conduction disturbances. Implantation traditional systems transvenous leads associated risk complications, such as pneumothorax perforation wall or device related infection. An alternative that may be used for permanent represented by the leadless pacemaker, implanted directly into target chamber. Such devices have been in Poland since 2016, but number procedures limited due...

10.33963/kp.15982 article EN Kardiologia Polska 2021-04-29

Young implantable cardioverter-defibrillator (ICD) recipients present a high rate of inappropriate interventions. Some them are caused by suboptimal pre-discharge programming the device. There conflicting data as regards antitachycardia pacing (ATP) effectiveness in children and young adults. We report our experience with ICD complications during 10 year follow-up.We analysed use ATP 63 patients aged 6-21 years. Antitachycardia (burst or ramp) was programmed ON 14 (22%), 49 (78%) had only...

10.1093/europace/euq263 article EN EP Europace 2010-07-21

Background: An increasing number of patients is referred for orthotopic heart transplantation (OHT) after previous implantable cardioverter-defibrillator (ICD) or cardiac resynchronisation therapy (CRT) device implantation. Aim: To assess the rate unsuccessful lead extractions during OHT and propose an appropriate management algorithm. Methods: The study population included 73 consecutive who underwent in our hospital between January 2009 December 2011. Results: In group, 36 (49.3%)...

10.5603/kp.2013.0009 article EN cc-by-nc-nd Kardiologia Polska 2013-02-20

Many cardiovascular diseases lead to heart failure, which is a progressive syndrome causing significant distress and limiting the quality of life, despite optimal cardiologic treatment. It estimated that about 26 000 people in Poland suffer from advanced this number growing. That why palliative care (PC) dedicated living with end‑stage cardiac should be urgently implemented Poland. Well‑organized PC may not only relieve symptoms improve life responding treatment but also support patients...

10.33963/kp.15276 article EN Kardiologia Polska 2020-04-24

Introduction: Cardiac implantable electronic devices (CIED) are a recognized form of therapy in cardiology. Apart from the benefits, use CIEDs is also associated with risk complications, and most important ones influencing treatment results prognosis infectious complications. Aim: This study aimed to calculate cost CIED-related infections, including transvenous lead extraction device reimplantation, perspective Polish hospital. Methods: A retrospective analysis hospitalization costs patients...

10.33963/kp.a2022.0144 article EN Kardiologia Polska 2022-09-30

Ensuring a haemodynamically effective cardiac rhythm is challenge in patients waiting for pacemaker reimplantation after transcutaneous lead extraction due to an infection of the implanted system.The authors report retrospective analysis temporary pacing with active fixation (AFTP) connected externalised transvenous (TLE) infection.AFTP was used 34 (12 women) aged from 38 88 years (mean 67.5 years). This represented 24.5% population undergoing TLE infective indications. In 32 cases,...

10.5603/kp.a2015.0093 article EN cc-by-nc-nd Kardiologia Polska 2015-05-19

Exacerbation of chronic heart failure (HF) is the most common cause hospitalization in adults, which associated with high morbidity and mortality rates, mainly due to HF exacerbation or sudden cardiac death (SCD). A novelty treatment reduced left ventricular ejection fraction (HFrEF) recent years has been approval sacubitril / valsartan, a drug belonging angiotensin receptor-neprilysin inhibitors (ARNIs). Sacubitril valsartan significantly reduces severity symptoms as well risk characterized...

10.33963/kp.14972 article EN Kardiologia Polska 2019-09-17

The risk of ischemic events gradually decreases after acute coronary syndrome (ACS), reaching a stable level 1 month, while the bleeding remains steady during whole period dual antiplatelet treatment (DAPT). Several de-escalation strategies aiming to enhance safety DAPT without depriving it its efficacy have been evaluated so far. We hypothesized that reduction ticagrelor maintenance dose month ACS and continuation until 12 months may improve adherence due better tolerability compared with...

10.5603/cj.a2021.0056 article EN cc-by-nc-nd Cardiology Journal 2021-06-07

Background: The use of subcutaneous implantable cardioverter-defibrillators (S-ICD) has been growing in Poland since 2014. Polish Registry S-ICD Implantations was run by the Heart Rhythm Section Cardiac Society between May 2020 and September 2022 to monitor implementation that therapy Poland. Aims: To investigate present state-of-the-art implantation Methods: Implanting centers reported clinical data patients undergoing implantations replacements, including age, sex, height, weight,...

10.33963/kp.a2023.0046 article EN Kardiologia Polska 2023-05-29

Introduction: Measuring the postpacing interval (PPI) and correcting for tachycardia cycle length (TCL) is an important entrainment response (ER). However, it may be impossible to measure PPI due electrical noise on mapping catheter. To overcome this problem, 2 alternative methods assessment of ER have been proposed: N+1 difference (N+1 DIFF) PPIR method. PPI‐TCL (PPI − TCL) correlates very well with assessed by new methods, but agreement TCL was established only in relation Moreover, not...

10.1111/j.1540-8167.2008.01425.x article EN Journal of Cardiovascular Electrophysiology 2009-02-02

Abstract Background LMNA mutations are most frequently involved in the pathogenesis of dilated cardiomyopathy with conduction disease. The goal this study was to identify mutations, estimate their frequency among Polish patients and characterize effect both vivo vitro . Methods Between January, 2008 June, 2012 two patient populations were screened for presence by direct sequencing: 66 including 27 heart transplant recipients 39 failure referred transplantation evaluation, 44 consecutive...

10.1186/1471-2350-14-55 article EN cc-by BMC Medical Genetics 2013-05-23
Coming Soon ...